177 related articles for article (PubMed ID: 11057028)
1. Dystrophinopathies in females.
Hausmanowa-Petrusewicz I; Fidziańska A; Niebrój-Dobosz I; Dorobek M; Bojakowski J
Folia Neuropathol; 2000; 38(1):7-12. PubMed ID: 11057028
[TBL] [Abstract][Full Text] [Related]
2. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy.
Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M
Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical staining of dystrophin on formalin-fixed paraffin-embedded sections in Duchenne/Becker muscular dystrophy and manifesting carriers of Duchenne muscular dystrophy.
Hoshino S; Ohkoshi N; Watanabe M; Shoji S
Neuromuscul Disord; 2000 Aug; 10(6):425-9. PubMed ID: 10899449
[TBL] [Abstract][Full Text] [Related]
4. Genetic and Early Clinical Manifestations of Females Heterozygous for Duchenne/Becker Muscular Dystrophy.
Papa R; Madia F; Bartolomeo D; Trucco F; Pedemonte M; Traverso M; Broda P; Bruno C; Zara F; Minetti C; Fiorillo C
Pediatr Neurol; 2016 Feb; 55():58-63. PubMed ID: 26718981
[TBL] [Abstract][Full Text] [Related]
5. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
Wang X; Xie Y; Zhang C; Liu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
[TBL] [Abstract][Full Text] [Related]
6. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
Voit T; Stuettgen P; Cremer M; Goebel HH
Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
[TBL] [Abstract][Full Text] [Related]
7. Utility of dystrophin and utrophin staining in childhood muscular dystrophy.
Sundaram C; Vydehi B; Meena K; Murthy J
Indian J Pathol Microbiol; 2004 Jul; 47(3):367-9. PubMed ID: 16295426
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism in muscle biopsies of Duchenne and Becker muscular dystrophy patients.
Anand A; Prabhakar S; Kaul D
Neurol India; 1999 Sep; 47(3):218-23. PubMed ID: 10514583
[TBL] [Abstract][Full Text] [Related]
9. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of PCR-deletion detection and immunohistochemistry in Brazilian Duchenne and Becker muscular dystrophy patients.
Werneck LC; Scola RH; Maegawa GH; Werneck MC
Am J Med Genet; 2001 Oct; 103(2):115-20. PubMed ID: 11568916
[TBL] [Abstract][Full Text] [Related]
11. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry in the diagnosis of dystrophinopathies.
Manole E
Rom J Neurol Psychiatry; 1995; 33(1):51-5. PubMed ID: 7547371
[TBL] [Abstract][Full Text] [Related]
13. Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy.
Viggiano E; Ergoli M; Picillo E; Politano L
Hum Genet; 2016 Jul; 135(7):685-98. PubMed ID: 27098336
[TBL] [Abstract][Full Text] [Related]
14. Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype.
Brioschi S; Gualandi F; Scotton C; Armaroli A; Bovolenta M; Falzarano MS; Sabatelli P; Selvatici R; D'Amico A; Pane M; Ricci G; Siciliano G; Tedeschi S; Pini A; Vercelli L; De Grandis D; Mercuri E; Bertini E; Merlini L; Mongini T; Ferlini A
BMC Med Genet; 2012 Aug; 13():73. PubMed ID: 22894145
[TBL] [Abstract][Full Text] [Related]
15. Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age.
Mercier S; Toutain A; Toussaint A; Raynaud M; de Barace C; Marcorelles P; Pasquier L; Blayau M; Espil C; Parent P; Journel H; Lazaro L; Andoni Urtizberea J; Moerman A; Faivre L; Eymard B; Maincent K; Gherardi R; Chaigne D; Ben Yaou R; Leturcq F; Chelly J; Desguerre I
Eur J Hum Genet; 2013 Aug; 21(8):855-63. PubMed ID: 23299919
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and pathological features of 50 children with Duchenne's muscular dystrophy].
Li QX; Yang H; Zhang N; Xiao B; Bi FF; Li J
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Oct; 14(10):746-50. PubMed ID: 23092565
[TBL] [Abstract][Full Text] [Related]
17. [Specific features of Becker Muscular Dystrophy patients and female carriers of Duchenne Muscular Dystrophy].
Magot A; Mercier S; Péréon Y
Arch Pediatr; 2015 Dec; 22(12 Suppl 1):12S31-6. PubMed ID: 26773584
[TBL] [Abstract][Full Text] [Related]
18. [Study of dystrophin gene non-deletion/duplication mutations causing Becker muscular dystrophy].
Cao JQ; Zhang C; Feng SW; Yang J; Li Z; Zhang M; Li SY; Sun XF; Wang YY; Zheng MY; Kong J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):308-12. PubMed ID: 21644230
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic characterization of manifesting carriers of DMD mutations.
Soltanzadeh P; Friez MJ; Dunn D; von Niederhausern A; Gurvich OL; Swoboda KJ; Sampson JB; Pestronk A; Connolly AM; Florence JM; Finkel RS; Bönnemann CG; Medne L; Mendell JR; Mathews KD; Wong BL; Sussman MD; Zonana J; Kovak K; Gospe SM; Gappmaier E; Taylor LE; Howard MT; Weiss RB; Flanigan KM
Neuromuscul Disord; 2010 Aug; 20(8):499-504. PubMed ID: 20630757
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Involvement in Dystrophin-Deficient Females: Current Understanding and Implications for the Treatment of Dystrophinopathies.
Lim KRQ; Sheri N; Nguyen Q; Yokota T
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32650403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
